Cargando…
Procalcitonin Is Not a Reliable Biomarker of Bacterial Coinfection in People With Coronavirus Disease 2019 Undergoing Microbiological Investigation at the Time of Hospital Admission
Admission procalcitonin measurements and microbiology results were available for 1040 hospitalized adults with coronavirus disease 2019 (from 48 902 included in the International Severe Acute Respiratory and Emerging Infections Consortium World Health Organization Clinical Characterisation Protocol...
Autores principales: | Relph, Katharine A, Russell, Clark D, Fairfield, Cameron J, Turtle, Lance, de Silva, Thushan I, Siggins, Matthew K, Drake, Thomas M, Thwaites, Ryan S, Abrams, Simon, Moore, Shona C, Hardwick, Hayley E, Oosthuyzen, Wilna, Harrison, Ewen M, Docherty, Annemarie B, Openshaw, Peter J M, Baillie, J Kenneth, Semple, Malcolm G, Ho, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070482/ https://www.ncbi.nlm.nih.gov/pubmed/35531376 http://dx.doi.org/10.1093/ofid/ofac179 |
Ejemplares similares
-
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study
por: Drake, Thomas M, et al.
Publicado: (2021) -
Viral Coinfections in Hospitalized Coronavirus Disease 2019 Patients Recruited to the International Severe Acute Respiratory and Emerging Infections Consortium WHO Clinical Characterisation Protocol UK Study
por: Vink, Elen, et al.
Publicado: (2022) -
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study
por: Russell, Clark D, et al.
Publicado: (2021) -
Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19
por: Thwaites, Ryan S, et al.
Publicado: (2021) -
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
por: Turtle, Lance, et al.
Publicado: (2023)